ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ALT Altimmune Inc

5,9773
0,0673 (1,14%)
Vor Marktöffnung
Zuletzt aktualisiert: 14:51:31
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Altimmune Inc ALT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,0673 1,14% 5,9773 14:51:31
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,91
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
20.6.202413:30GLOBEAltimmune to Participate in the Piper Sandler 2nd Annual..
20.6.202411:45PRNUSAltimmune, Inc. Securities Fraud Class Action Lawsuit..
18.6.202413:30GLOBEAltimmune Announces Oral Presentations of Pemvidutide..
17.6.202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
10.6.202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
05.6.202413:00GLOBEAltimmune Presents Data at EASL International Liver..
05.6.202411:45PRNUSAltimmune, Inc. Sued for Securities Law Violations -..
29.5.202413:31GLOBEAltimmune to Participate at Two Upcoming Investor..
29.5.202413:30GLOBEAltimmune to Present Clinical Data from Pemvidutide at..
29.5.202411:45PRNUSThe Gross Law Firm Notifies Shareholders of Altimmune,..
21.5.202415:00PRNUSRoundhill Investments Launches GLP-1 & Weight Loss ETF..
21.5.202411:45PRNUSThe Gross Law Firm Notifies Altimmune, Inc. Investors of a..
14.5.202411:45PRNUSContact The Gross Law Firm by July 5, 2024 Deadline to Join..
10.5.202411:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
09.5.202423:51PRNUSINVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors..
09.5.202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202413:04EDGAR2Form 8-K - Current report
09.5.202413:00GLOBEAltimmune Announces First Quarter 2024 Financial Results and..
07.5.202413:30GLOBEAltimmune to Participate at Two Upcoming Investor..
02.5.202413:30GLOBEAltimmune to Report First Quarter 2024 Financial Results and..
01.5.202413:30GLOBEAltimmune to Participate at Two Upcoming Conferences
25.4.202423:24GLOBEAltimmune Statement on the Passing of Dr. Stephen Harrison
27.3.202412:00GLOBEAltimmune Announces Positive Lean Mass Preservation Data for..
27.3.202411:57IHMARKETNEWSU.S. Stock Index Futures Point to a Rebound, Oil See..
20.3.202412:30GLOBEAltimmune to Report Fourth Quarter and Full Year 2023..
14.2.202418:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202412:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.2.202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202417:49EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05.1.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202413:30GLOBEAltimmune Announces Presentation of Pemvidutide Clinical..
08.12.202314:35GLOBEWater Tower Research US Climate Virtual Investor Conference:..
04.12.202314:35GLOBEWater Tower Research US Climate Investor Conference Agenda..
30.11.202322:28EDGAR2Form 8-K - Current report
30.11.202322:24GLOBEAltimmune Announces Positive Topline Results from MOMENTUM..
07.11.202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:06EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht